# US Celiac Disease Treatment Market > US Celiac Disease Treatment Market Research Report: By Treatment Type (Gluten Free Diet, Vitamin and Minerals Supplements, Medical Therapies) and By End User (Hospitals and Clinics, Research Centers, Others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 12.93% - **2024:** $ 160.3 Million - **2025:** $ 181.03 Million - **2035:** $ 610.82 Million - **Key Players:** AbbVie Inc (US), Gluten Free Holdings Inc (US), General Mills Inc (US), Kraft Heinz Co (US), Nestle SA (CH), Pinnacle Foods Inc (US), Schär AG (IT), The Hain Celestial Group Inc (US) **Report ID:** MRFR/HC/11809-HCR · **Pages:** 100 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-celiac-disease-treatment-market-13334 --- ## Market Summary ## **US Celiac Disease Treatment Market Overview** **As per MRFR analysis, the US Celiac Disease Treatment Market Size was estimated at 115.37 (USD Million) in 2023. The US Celiac Disease Treatment Market Industry is expected to grow from 128.1(USD Million) in 2024 to 853.71 (USD Million) by 2035. The US Celiac Disease Treatment Market CAGR (growth rate) is expected to be around 18.819% during the forecast period (2025 - 2035).** ### **Key US Celiac Disease Treatment Market Trends Highlighted** Celiac disease has gained significant attention in the US, leading to an increase in demand for effective treatments and management options. One of the key market drivers is the rising prevalence of celiac disease, with estimates suggesting that about 1 in 100 Americans are affected by this autoimmune disorder, prompting healthcare providers to focus on better diagnostic mechanisms and therapeutic approaches. Growing awareness among the general public, coupled with increased screening efforts by healthcare professionals, has contributed to the identification of undiagnosed cases, further driving treatment demand. Opportunities in the US [Celiac Disease Treatment](../../../reports/celiac-disease-treatment-market-8474) Market are abundant, particularly in the development of alternative therapies beyond the traditional gluten-free diet.Research is ongoing into pharmacological treatments that can provide symptom relief and improve patients' quality of life for those who accidentally consume gluten. Companies focused on innovations in enzyme supplementation and the development of novel dietary products tailored for celiac patients are well-positioned to capture this growing market segment. Recent trends indicate a rise in the acceptance and availability of gluten-free products across retail and dining establishments, reflecting a shift in consumer preferences. The US food industry is responding with a wider selection of gluten-free options, which enhances the quality of life for celiac patients.Furthermore, the increased collaboration between food manufacturers and health organizations is fostering the development of safe consumption practices and raising standards within the food industry. As celiac disease awareness grows, support networks and resources for patients continue to evolve, providing crucial information and community support that aids in the management of the condition. Overall, a combination of increasing prevalence, novel treatment opportunities, and changing consumer behavior denotes dynamic progress within the US Celiac Disease Treatment Market. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Celiac Disease Treatment Market Drivers** ### **Increasing Awareness and Diagnosis of Celiac Disease** The growing awareness of celiac disease among healthcare professionals and the general public is significantly driving the US Celiac Disease Treatment Market Industry. According to data from the National Institutes of Health, it is estimated that only 30% of the individuals with celiac disease are currently diagnosed, implying that a substantial portion of the population remains undiagnosed. With the recent initiatives by the Celiac Disease Foundation to promote awareness and educate physicians, there has been a notable increase in diagnoses by approximately 7% annually over the past five years. This rising diagnostic rate is contributing to the expanding treatment market as more individuals seek therapeutic options, fostering growth in the US Celiac Disease Treatment Market Industry, which is projected to thrive through increased patient demand for effective treatments. ### **Advancements in Treatment Options** There have been significant advancements in treatment options for celiac disease that are driving the US Celiac Disease Treatment Market Industry. New therapeutic methods, including enzyme therapies aimed at enhancing gluten digestion, are being developed and validated through ongoing Research and Development activities. According to the U.S. Food and Drug Administration, over 15 new treatments related to celiac disease have received investigational new drug status in the past three years, signaling a rapid evolution of the treatment landscape. This offers patients more choices beyond the traditional gluten-free diet, which not only enhances patient outcomes but is also expected to significantly increase the overall market value. ### **Rising Prevalence of Celiac Disease** The increasing prevalence of celiac disease within the United States acts as a major driver for the US Celiac Disease Treatment Market Industry. Recent estimates from the Centers for Disease Control and Prevention indicate that prevalence rates have risen by 5% over the last decade, currently affecting approximately 1 in 133 individuals in the American population. This rise is encouraging greater research initiatives and driving the need for more comprehensive treatment options, contributing to market growth. Organizations such as the American Gastroenterological Association are actively involved in advocating for improved celiac disease management strategies, thereby raising attention towards this condition and indirectly boosting the treatment market. ## **US Celiac Disease Treatment Market Segment Insights** ### **Celiac Disease Treatment Market Treatment Type Insights** The US Celiac Disease Treatment Market encompasses a diverse range of Treatment Types, primarily focusing on Gluten Free Diet, Vitamin and Minerals Supplements, and Medical Therapies. Within this market, the Gluten Free Diet plays a pivotal role as the primary treatment approach, offering a dietary modification that is crucial for patients with celiac disease. Adhering to a strict gluten-free diet not only alleviates symptoms but also aids in healing the intestinal lining, which is vital for long-term health and well-being. This dietary approach is widely recognized among healthcare professionals and patients alike as the cornerstone of celiac disease management, significantly impacting the development of numerous gluten-free products within the U.S. food industry. Vitamin and Minerals Supplements hold a significant position in the treatment realm, addressing the nutritional deficiencies commonly associated with celiac disease. Patients often suffer from malabsorption issues, leading to deficiencies in essential vitamins and minerals. Therefore, supplementation becomes a strategic intervention to restore nutritional balance and support overall health. This aspect not only enhances patient quality of life but also fosters an ongoing demand for fortified products within the market, as awareness of nutritional needs continues to grow.Medical Therapies, while not the primary treatment, are gaining traction as research progresses. These therapies aim to provide additional options for patients who may struggle with strict dietary adherence or wish to mitigate symptoms more effectively. Ongoing Research and Development efforts are focusing on pharmaceutical solutions, which may offer innovative methods to manage celiac disease through mechanisms that reduce gluten-induced damage. As the medical community becomes more adept at addressing the complexities of celiac disease, the potential for these therapies to reshape treatment paradigms grows, contributing to a more comprehensive management strategy.Overall, the segmentation within the US Celiac Disease Treatment Market reflects a multifaceted approach to managing the condition. The interplay between dietary management, supplementation, and emerging medical therapies underscores the importance of a holistic treatment plan that addresses the diverse needs of patients. This market's growth is driven by a combination of increasing awareness, evolving dietary habits, and advancements in medical options, resulting in a dynamic landscape that continues to adapt to the needs of individuals affected by celiac disease. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Celiac Disease Treatment Market End User Insights** The End User segment of the US Celiac Disease Treatment Market reflects a crucial landscape shaped by various healthcare providers, including Hospitals and Clinics, Research Centers, and Others. Hospitals and Clinics play a pivotal role as primary care settings where patients receive diagnoses and therapeutic interventions for celiac disease. Their accessibility and diverse treatment options cater to a significant patient base that seeks timely management of this autoimmune disorder. Research Centers contribute to the advancement of understanding and effective treatment strategies, fostering innovation through clinical trials and comprehensive studies on celiac disease. This ongoing research significantly enhances the treatment landscape and provides additional avenues for patient care. Furthermore, the 'Others' category encompasses outpatient facilities, laboratories, and specialized practices, which collectively assist in addressing the unique needs of celiac patients. The growing awareness of celiac disease, along with an increased emphasis on gluten-free diets, continues to drive engagement across all these end user domains, leading to improved patient outcomes and quality of life. With a focus on tailored treatment approaches and continued research efforts, the US Celiac Disease Treatment Market stands poised for ongoing development across its End User segment. ## **US Celiac Disease Treatment Market Key Players and Competitive Insights** The US Celiac Disease Treatment Market is characterized by a growing awareness of gluten-related disorders and the increasing prevalence of celiac disease among the population. This has led to a surge in demand for gluten-free products and therapeutic options that cater specifically to individuals diagnosed with this autoimmune condition. Companies operating within this market are focusing on innovation, product development, and strategic partnerships to enhance their offerings and capture greater market share. The competition is intensifying as businesses strive to meet the unique dietary needs of consumers while ensuring product quality and taste. As healthcare providers increasingly recognize the importance of a gluten-free diet in managing celiac disease, the market presents a dynamic landscape for both established players and new entrants.Dr. Schär stands out in the US Celiac Disease Treatment Market due to its extensive range of gluten-free products designed to meet the dietary requirements of those affected by celiac disease. The company has a strong market presence, underpinned by its commitment to research and development, which enables it to offer high-quality, safe, and delicious gluten-free options. Dr. Schär is known for its diverse product line, which includes bread, pasta, snacks, and mixes. One of its notable strengths is its consistent focus on maintaining high safety standards and transparent labeling. By prioritizing consumer education and health, Dr. Schär has built a loyal customer base and established itself as a trusted brand among consumers seeking celiac-friendly food alternatives in the US market.Hormel Foods plays a significant role in the US Celiac Disease Treatment Market with a solid focus on innovation and the development of gluten-free options within its product portfolio. The company has made strategic investments in the sector, aiming to expand its offerings and reach health-conscious consumers who require gluten-free diets due to celiac disease. Hormel Foods has introduced key products that cater to this audience, including gluten-free snacks and meal solutions, emphasizing convenience and taste. The company's strengths lie in its established brand reputation and its ability to leverage its extensive distribution network, making gluten-free options more accessible to consumers across the United States. Hormel Foods has also been active in pursuing mergers and acquisitions to enhance its presence in the gluten-free market, thereby strengthening its position and expanding its reach in a competitive landscape. ### **Key Companies in the US Celiac Disease Treatment Market Include** ## **US Celiac Disease Treatment Market Industry Developments** The US Celiac Disease Treatment Market has experienced significant developments recently, driven by an increasing prevalence of celiac disease and rising consumer demand for gluten-free products. Notable recent growth has been observed in companies such as Dr. Schär and Hormel Foods, which continue to expand their gluten-free product lines. In September 2023, Takeda announced an uptick in investment aimed at Research and Development for novel therapies, responding to a market increasingly focused on personalized medicine. Additionally, Kraft Heinz and General Mills are actively improving their existing gluten-free product offerings to enhance market share. In August 2023, Tate and Lyle completed the acquisition of a smaller gluten-free ingredient company to strengthen its portfolio. The market’s valuation has been bolstered by increased awareness and stringent labeling regulations surrounding gluten-free products. Over the past few years, merger and acquisition activity, particularly by major players such as Nestlé and Pinnacle Foods, has amplified competition within the sector. The overall growth trajectory of this market underscores a commitment to innovative treatments and product development aimed at addressing the needs of those affected by celiac disease in the US. ## **US Celiac Disease Treatment Market Segmentation Insights** ### **Celiac Disease Treatment Market Treatment Type Outlook** ### **Celiac Disease Treatment Market End User Outlook** - Hospitals and Clinics - Research Centers - Others ## Market Drivers ### Growing Awareness of Celiac Disease The increasing awareness of celiac disease among the general population is a crucial driver for the celiac disease-treatment market. Educational campaigns and advocacy efforts have led to a better understanding of the disease, its symptoms, and the importance of diagnosis. As more individuals recognize the signs of celiac disease, the demand for diagnostic testing and treatment options rises. This heightened awareness is reflected in the growing number of diagnosed cases, which has been estimated to be around 1 in 133 individuals in the US. Consequently, the celiac disease-treatment market is likely to expand as healthcare providers respond to the increasing need for effective management solutions. ### Rising Incidence of Autoimmune Disorders The rising incidence of autoimmune disorders, including celiac disease, is a significant driver for the celiac disease-treatment market. Research indicates that autoimmune diseases are becoming more prevalent in the US, with celiac disease being one of the most common. This trend is likely influenced by various factors, including environmental triggers and genetic predisposition. As the number of individuals diagnosed with celiac disease increases, the demand for effective treatment options and dietary management strategies will also rise. This growing patient population presents opportunities for market expansion, as healthcare providers seek to address the needs of those affected by this condition. ### Technological Advancements in Diagnostics Technological advancements in diagnostic tools are transforming the celiac disease-treatment market. Innovations such as non-invasive testing methods and improved serological assays are making it easier for healthcare providers to diagnose celiac disease accurately and efficiently. These advancements not only enhance patient outcomes but also contribute to the overall growth of the market. The introduction of point-of-care testing devices allows for quicker diagnosis, which is essential for timely treatment initiation. As diagnostic technologies continue to evolve, the celiac disease-treatment market is expected to benefit from increased patient throughput and improved access to care. ### Regulatory Support for Gluten-Free Products Regulatory frameworks supporting gluten-free labeling and product development significantly impact the celiac disease-treatment market. The US Food and Drug Administration (FDA) has established guidelines that define gluten-free products, ensuring that consumers have access to safe food options. This regulatory support not only enhances consumer confidence but also encourages manufacturers to innovate and expand their gluten-free product lines. As a result, the market for gluten-free foods and treatments is projected to grow, with estimates suggesting a compound annual growth rate (CAGR) of approximately 9% over the next few years. This growth is indicative of the increasing demand for safe dietary options among individuals with celiac disease. ### Increased Investment in Research and Development Increased investment in research and development (R&D) within the celiac disease-treatment market is driving innovation and improving treatment options. Pharmaceutical companies and research institutions are focusing on developing new therapies, including enzyme-based treatments and immunotherapies, aimed at managing celiac disease more effectively. This influx of funding is likely to lead to breakthroughs that could change the landscape of treatment for patients. As R&D efforts continue to advance, the celiac disease-treatment market may witness the introduction of novel therapies that enhance patient quality of life and adherence to gluten-free diets. ## Future Outlook The [Celiac Disease Treatment Market](https://www.marketresearchfuture.com/reports/celiac-disease-treatment-market-8474) is projected to grow at a 12.93% CAGR from 2025 to 2035, driven by increasing awareness, innovative therapies, and rising diagnosis rates. **New opportunities:** - Development of personalized gluten-free meal plans for patients. - Expansion of telehealth services for remote patient monitoring. - Investment in research for novel therapeutic agents targeting celiac disease. By 2035, the market is expected to achieve substantial growth, driven by innovative solutions and increased patient engagement. ## Segment Insights ### By Treatment Type: Gluten Free Diet (Largest) vs. Medical Therapies (Fastest-Growing) The US celiac disease-treatment market is notably characterized by the dominance of the Gluten Free Diet, which commands the largest share among treatment types. This segment is widely recognized for its fundamental role in managing celiac disease, making it the go-to option for many patients. In contrast, Medical Therapies are emerging rapidly due to growing interest in pharmaceutical interventions that promise greater convenience and accessibility for patients. The growth trends within the segment are propelled by increasing awareness of celiac disease and its management. As lifestyles become more health-conscious, patients are seeking alternative treatment options to complement dietary restrictions. Medical Therapies, being the fastest-growing segment, are drawing significant attention from researchers and pharmaceutical companies aiming to innovate solutions that enhance quality of life for those affected by celiac disease. Gluten Free Diet (Dominant) vs. Medical Therapies (Emerging) The Gluten Free Diet stands as the dominant option within the US celiac disease treatment market, being fundamental for managing symptoms and promoting intestinal healing. Many individuals with celiac disease view this lifestyle change as essential to avoid adverse health effects. In contrast, Medical Therapies represent an emerging landscape that complements dietary adherence. These therapies are being developed to target the underlying mechanisms of the disease, potentially offering an alternative treatment route. This segment is gaining traction among healthcare providers and patients due to its promise for improving patient adherence to treatment and broadening the options available. The focus on research and development in this sector indicates a shift toward a more multifaceted approach in managing celiac disease. ### By End User: Hospitals and Clinics (Largest) vs. Research Centers (Fastest-Growing) In the US celiac disease-treatment market, Hospitals and Clinics currently capture the largest share due to their comprehensive patient care and access to advanced treatment options. This segment benefits from established healthcare networks and the ability to provide immediate care, allowing them to cater to a large number of patients. On the other hand, Research Centers are gaining traction, making them an increasingly vital part of the market landscape. Recently, Research Centers have demonstrated remarkable growth driven by the need for innovative treatment solutions and the ongoing emphasis on research into celiac disease. These centers play a crucial role in advancing knowledge and developing new therapies, attracting more funding and partnerships with pharmaceutical companies. This momentum positions them as the fastest-growing segment, reflecting a dynamic shift towards research-focused treatment approaches. Hospitals and Clinics (Dominant) vs. Research Centers (Emerging) Hospitals and Clinics dominate the segment due to their established infrastructure, expertise in patient management, and comprehensive care models. They offer integrated services, including diagnostics, treatment, and patient education, ensuring continuity of care for individuals with celiac disease. This segment is characterized by a high patient volume, enabling healthcare providers to efficiently utilize resources and develop specialized programs. Conversely, Research Centers are emerging as crucial players, focusing on innovative therapies and clinical trials. They are dedicated to enhancing treatment options and understanding the disease pathophysiology, often collaborating with academic institutions and industry partners. The growth of this segment is fueled by increased investment in research, leading to a more profound understanding of celiac disease and potential therapeutic advancements. ## Competitive Benchmarking The celiac disease-treatment market is currently characterized by a dynamic competitive landscape, driven by increasing awareness of gluten-related conditions and a growing demand for gluten-free products. Major players such as AbbVie Inc (US), General Mills Inc (US), and The Hain Celestial Group Inc (US) are strategically positioning themselves through innovation and product diversification. AbbVie Inc (US) has focused on developing novel therapeutic options, while General Mills Inc (US) has expanded its gluten-free product lines to cater to a broader consumer base. The Hain Celestial Group Inc (US) emphasizes sustainability and health-conscious offerings, which collectively shape a competitive environment that prioritizes consumer preferences and regulatory compliance.Key business tactics within this market include localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness to market demands. The competitive structure appears moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for niche players to thrive, while larger companies leverage their scale to dominate market share. The collective influence of these players fosters a competitive atmosphere that encourages innovation and responsiveness to consumer needs. In October AbbVie Inc (US) announced a partnership with a leading biotechnology firm to accelerate the development of a new treatment for celiac disease. This strategic move is significant as it not only enhances AbbVie’s research capabilities but also positions the company to potentially lead in a market that is increasingly focused on personalized medicine. Such collaborations may pave the way for breakthroughs that could redefine treatment paradigms in the coming years. In September General Mills Inc (US) launched a new line of gluten-free snacks aimed at children, reflecting a strategic focus on expanding its product offerings to capture younger demographics. This initiative is crucial as it aligns with the growing trend of health-conscious eating among families, thereby enhancing brand loyalty and market penetration. The introduction of these products may also stimulate competition among peers to innovate in the gluten-free segment. In August The Hain Celestial Group Inc (US) unveiled a sustainability initiative aimed at reducing its carbon footprint across its gluten-free product lines. This move underscores the increasing importance of sustainability in consumer purchasing decisions and positions the company favorably among environmentally conscious consumers. The initiative may also serve as a competitive differentiator in a market where consumers are increasingly seeking brands that align with their values. As of November current trends in the celiac disease-treatment market indicate a shift towards digitalization, sustainability, and the integration of AI technologies in product development and marketing strategies. Strategic alliances are becoming increasingly vital, as companies seek to leverage complementary strengths to enhance their competitive positioning. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability, reflecting a broader shift in consumer expectations and market dynamics. ## Recent News & Developments The US Celiac Disease Treatment Market has experienced significant developments recently, driven by an increasing prevalence of celiac disease and rising consumer demand for gluten-free products. Notable recent growth has been observed in companies such as Dr. Schär and Hormel Foods, which continue to expand their gluten-free product lines. In September 2023, Takeda announced an uptick in investment aimed at Research and Development for novel therapies, responding to a market increasingly focused on personalized medicine. Additionally, Kraft Heinz and General Mills are actively improving their existing gluten-free product offerings to enhance market share. In August 2023, Tate and Lyle completed the acquisition of a smaller gluten-free ingredient company to strengthen its portfolio. The market’s valuation has been bolstered by increased awareness and stringent labeling regulations surrounding gluten-free products. Over the past few years, merger and acquisition activity, particularly by major players such as Nestlé and Pinnacle Foods, has amplified competition within the sector. The overall growth trajectory of this market underscores a commitment to innovative treatments and product development aimed at addressing the needs of those affected by celiac disease in the US. ## Report Scope | MARKET SIZE 2024 | 160.3(USD Million) | | --- | --- | | MARKET SIZE 2025 | 181.03(USD Million) | | MARKET SIZE 2035 | 610.82(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 12.93% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | AbbVie Inc (US), Gluten Free Holdings Inc (US), General Mills Inc (US), Kraft Heinz Co (US), Nestle SA (CH), Pinnacle Foods Inc (US), Schär AG (IT), The Hain Celestial Group Inc (US) | | Segments Covered | Treatment Type, End User | | Key Market Opportunities | Emerging gluten-free product innovations cater to increasing consumer demand in the celiac disease-treatment market. | | Key Market Dynamics | Rising demand for gluten-free products drives innovation and competition in the celiac disease-treatment market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the current valuation of the US celiac disease-treatment market as of 2024?** A: The market valuation was $160.3 Million in 2024. **Q: What is the projected market valuation for the US celiac disease-treatment market in 2035?** A: The projected valuation for 2035 is $610.82 Million. **Q: What is the expected CAGR for the US celiac disease-treatment market during the forecast period 2025 - 2035?** A: The expected CAGR during this period is 12.93%. **Q: Which companies are considered key players in the US celiac disease-treatment market?** A: Key players include AbbVie Inc, Gluten Free Holdings Inc, General Mills Inc, Kraft Heinz Co, Nestle SA, Pinnacle Foods Inc, Schär AG, and The Hain Celestial Group Inc. **Q: What are the main treatment types in the US celiac disease-treatment market?** A: The main treatment types include Gluten Free Diet, Vitamin and Minerals Supplements, and Medical Therapies. **Q: How did the Gluten Free Diet segment perform in 2024?** A: In 2024, the Gluten Free Diet segment was valued at $80.15 Million. **Q: What is the projected growth for the Vitamin and Minerals Supplements segment by 2035?** A: The Vitamin and Minerals Supplements segment is projected to reach $184.25 Million by 2035. **Q: What end-user segments are present in the US celiac disease-treatment market?** A: End-user segments include Hospitals and Clinics, Research Centers, and Others. **Q: What was the valuation of the Hospitals and Clinics segment in 2024?** A: The Hospitals and Clinics segment was valued at $80.15 Million in 2024. **Q: What is the expected performance of the Others segment by 2035?** A: The Others segment is expected to grow to $121.16 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-celiac-disease-treatment-market-13334*